WILLIAM JL RIEFLIN - 25 May 2022 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact for William Rieflin
Issuer symbol
RAPT
Transactions as of
25 May 2022
Net transactions value
$0
Form type
4
Filing time
26 May 2022, 18:18:04 UTC
Previous filing
04 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Stock Option (right to buy) Award $0 +8,500 $0.000000 8,500 25 May 2022 Common Stock 8,500 $13.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option shall vest on the earlier of (i) May 25, 2023, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2023, subject to the Reporting Person's continuous service through each applicable vesting date.